Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 23
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Novel risk loci for COVID-19 hospitalization among admixed American populations

  • Diz-de Almeida, Silvia|||0000-0003-2813-8928
  • Cruz, Raquel|||0000-0002-6964-8898
  • Luchessi, Andre D.
  • Lorenzo-Salazar, José M.
  • López de Heredia, Miguel|||0000-0003-2826-9565
  • Quintela, Inés|||0000-0002-0239-7975
  • González-Montelongo, Rafaela
  • Nogueira Silbiger, Vivian|||0000-0002-9252-0278
  • Sevilla Porras, Marta
  • Tenorio Castaño, Jair Antonio|||0000-0002-5308-2316
  • Nevado, Julián|||0000-0001-5611-2659
  • Aguado, José María|||0000-0002-9520-8255
  • Aguilar, Carlos
  • Aguilera-Albesa, Sergio|||0000-0003-3540-1448
  • Almadana, Virginia
  • Almoguera, Berta|||0000-0002-5599-2954
  • Alvarez, Nuria
  • Andreu-Bernabeu, Álvaro
  • Arana-Arri, Eunate|||0000-0001-9759-333X
  • Arango, Celso|||0000-0003-3382-4754
  • Arranz, María Jesús|||0000-0002-6757-9198
  • Artiga, Maria-Jesus
  • Baptista-Rosas, Raúl C.|||0000-0002-0273-4740
  • Barreda Sánchez, María
  • Belhassen-Garcia, Moncef
  • Bezerra, Joao F.
  • Bezerra, Marcos AC.
  • Boix-Palop, Lucía|||0000-0002-4080-0008
  • Brion, María|||0000-0001-7463-2148
  • Brugada, Ramon|||0000-0001-6607-3032
  • Bustos, Matilde
  • Calderón, Enrique J.|||0000-0002-3166-5086
  • Carbonell, Cristina|||0000-0002-6271-5111
  • Castaño, Luis|||0000-0003-0437-9401
  • Castelao, Jose E.
  • Conde-Vicente, Rosa
  • Cordero-Lorenzana, M. Lourdes
  • Cortes-Sanchez, Jose L.
  • Corton, Marta|||0000-0003-0087-1626
  • Darnaude, M. Teresa
  • De Martino-Rodríguez, Alba|||0000-0002-2436-9852
  • Campo Pérez, Víctor del|||0000-0002-9424-9653
  • Diaz de Bustamante, Aranzazu
  • Domínguez-Garrido, Elena|||0000-0002-2066-0511
  • Eirós, Rocío
  • Fariñas, M. Carmen
  • Fernandez-Nestosa, María J.|||0000-0001-7764-7791
  • Fernández-Robelo, Uxía
  • Fernández-Rodríguez, Amanda|||0000-0002-5110-2213
  • Fernández-Villa, Tania|||0000-0002-9049-3026
  • Gago-Dominguez, Manuela
  • Gil-Fournier, Belén
  • Gómez-Arrue, Javier
  • González Álvarez, Beatriz
  • González Bernaldo de Quirós, Fernan
  • González-Neira, Anna
  • González-Peñas, Javier|||0000-0002-3850-3012
  • Gutiérrez-Bautista, Juan F.|||0000-0003-1374-0756
  • Herrero, María José
  • Herrero-Gonzalez, Antonio
  • Jimenez-Sousa, María A.
  • Lattig, María Claudia|||0000-0003-2113-9266
  • Liger Borja, Anabel
  • Lopez-Rodriguez, Rosario
  • Mancebo, Esther
  • Martín-López, Caridad
  • Martín, Vicente|||0000-0003-0552-2804
  • Martinez-Nieto, Oscar
  • Martinez-Lopez, Iciar
  • Martinez-Resendez, Michel F.
  • Martinez-Perez, Angel|||0000-0002-5934-1454
  • Mazzeu, Juliana F.
  • Merayo Macías, Eleuterio
  • Minguez, Pablo|||0000-0003-4099-9421
  • Moreno Cuerda, Victor
  • Oliveira, Silviene F.|||0000-0002-7741-0257
  • Ortega-Paino, Eva
  • Parellada, Mara|||0000-0001-7977-3601
  • Paz-Artal, Estela|||0000-0002-0646-2375
  • Santos, Ney PC.
  • Pérez-Matute, Patricia
  • Perez, Patricia
  • Pérez-Tomás, M. Elena|||0000-0002-5429-3414
  • Perucho, Teresa
  • Pinsach-Abuin, Mellina
  • Pita, Guillermo|||0000-0003-2393-0510
  • Pompa-Mera, Ericka N.
  • Porras-Hurtado, Gloria L.
  • Pujol, Aurora|||0000-0002-9606-0600
  • Ramiro-León, Soraya
  • Resino, Salvador|||0000-0001-8783-0450
  • Fernandes, Marianne R.
  • Rodríguez-Ruiz, Emilio
  • Rodriguez-Artalejo, Fernando
  • Rodriguez-Garcia, José A.
  • Ruiz-Cabello, Francisco
  • Ruiz-Hornillos, Javier
  • Ryan, Pablo|||0000-0002-4212-7419
  • Soria Fernández, José Manuel|||0000-0002-6226-4293
  • Souto, Juan Carlos|||0000-0003-2092-5142
  • Tamayo, Eduardo
  • Tamayo-Velasco, Alvaro
  • Taracido-Fernandez, Juan Carlos
  • Teper, AlejandroHospital de Niños Ricardo Gutierrez (Buenos Aires, Argentina)
  • Torres-Tobar, Lilian
  • Urioste, Miguel|||0000-0001-7583-7305
  • Valencia-Ramos, Juan
  • Yáñez, Zuleima
  • Zarate, Ruth N.
  • De Rojas, Itziar|||0000-0002-2148-381X
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
  • Sánchez, Pascual
  • Real, Luis M.|||0000-0003-4932-7429
  • Guillén-Navarro, Encarna|||0000-0002-2915-7381
  • Ayuso, Carmen|||0000-0002-9606-6957
  • Parra, Esteban J.|||0000-0002-2057-8577
  • Riancho, José A.|||0000-0003-0691-8755
  • Rojas-Martinez, Augusto|||0000-0003-3765-6778
  • Flores, Carlos|||0000-0001-5352-069X
  • Lapunzina, Pablo|||0000-0002-6324-4825
  • Carracedo, Ángel|||0000-0003-1085-8986
The genetic basis of severe COVID-19 has been thoroughly studied, and many genetic risk factors shared between populations have been identified. However, reduced sample sizes from non-European groups have limited the discovery of population-specific common risk loci. In this second study nested in the SCOURGE consortium, we conducted a genome-wide association study (GWAS) for COVID-19 hospitalization in admixed Americans, comprising a total of 4702 hospitalized cases recruited by SCOURGE and seven other participating studies in the COVID-19 Host Genetic Initiative. We identified four genome-wide significant associations, two of which constitute novel loci and were first discovered in Latin American populations (BAZ2B and DDIAS). A trans-ethnic meta-analysis revealed another novel cross-population risk locus in CREBBP. Finally, we assessed the performance of a cross-ancestry polygenic risk score in the SCOURGE admixed American cohort. This study constitutes the largest GWAS for COVID-19 hospitalization in admixed Latin Americans conducted to date. This allowed to reveal novel risk loci and emphasize the need of considering the diversity of populations in genomic research.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Convergent antisense transcription primes hosting genes for stress responsiveness in plants

  • Zacharaki, Vasiliki|||0000-0002-5543-2332
  • Quevedo, Martí|||0000-0001-7747-7710
  • Nardeli, Sarah Muniz|||0000-0001-8858-807X
  • Meena, Shiv Kumar|||0000-0002-3191-3254
  • Monte, Elena|||0000-0002-7340-9355
  • Kindgren, Peter|||0000-0003-0947-2648
Plants need to constantly surveil their surroundings to adapt to environmental fluctuations, which they achieve primarily through transcriptional reprogramming. Thus, plants are excellent models for identifying novel transcriptional regulatory mechanisms. In this study, we characterize the regulation mediated by long non-coding transcription that initiates on the complementary strand in the 5ʹ end of coding genes (convergent antisense transcription, CASt). In Arabidopsis, CASt is associated with stress-responsive genes that are highly expressed. Our analysis shows that CASt depends on a specific gene architecture that is evolutionarily conserved in higher plants. CASt is present in genes with an extended first intron and over-represented in genes encoding functional transporters in Arabidopsis, such as the AMINO ACID PERMEASE (AAP) transporter family. Experimental evidence points to a role for CASt in priming their host genes for stress responsiveness in evolutionary divergent plant species. Furthermore, we were able to predict stress responsiveness in rice AAP genes based on the presence of a long first intron and CASt. Collectively, we show an evolutionary strategy and regulatory mechanism specific to plants for enhancing stress responsiveness through modification of gene architecture and antisense transcription.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The non-conventional peptidome of Arabidopsis flower development

  • Álvarez-Urdiola, Raquel|||0000-0001-8943-5147
  • Matus, José Tomás|||0000-0002-9196-1813
  • González-Miguel, Víctor M.|||0009-0006-8963-4588
  • Bernardo-Faura, Martí|||0000-0002-8023-3263
  • Riechmann, José Luis|||0000-0003-1108-1945
Unraveling the complexities of genomic data has revealed that the protein coding capacity of eukaryotic genomes has been underestimated. Eukaryotic genomes contain numerous unannotated short open reading frames (sORFs) that, localized in different types of RNA molecules, including long non-coding RNAs, may encode and produce biologically functional peptides. This study focuses on the characterization of the Arabidopsis (Arabidopsis thaliana) sORF-derived flower peptidome, using the floral homeotic mutants apetala1, apetala2, apetala3, pistillata, and agamous in comparison to the wild type. For peptide identification by mass spectrometry (MS), we created an extensive database of hypothetical Arabidopsis peptides, which comprised putative sORF-encoded peptides from intergenic regions, untranslated regions, "non-coding" RNAs and other transcripts. In total, 1,874 hypothetical peptides were detected by MS, of which 132 were selected as higher-confidence peptides for further studies. Sixty of these higher-confidence peptides were predicted to be specifically expressed, or at least enriched, in particular floral organs. Approximately 25% of them belonged to putative gene families in A. thaliana, and 103 had potential homologs in other plant species. Additionally, distinct gene expression patterns were observed, in many cases consisting of specific expression in stamens during flower development.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A novel MoClo-mediated intron insertion system facilitates enhanced transgene expression in Chlamydomonas reinhardtii

  • Aschern, Moritz|||0000-0003-1474-7562
  • Braad, Jochem
  • Milito, Alfonsina|||0000-0002-5541-6113
  • Alzuria, David|||0009-0002-7345-7899
  • Yang, Jae-Seong|||0000-0001-9910-3170
The Chlamydomonas Modular Cloning (MoClo) toolkit allows for straightforward and flexible construction of genetic modules for geneexpression in the microalgal model species, fosteringdevelopments in algal biotechnology. Efficiently expressing transgenes from the nuclear genome of C. reinhardtii requires the proper insertion of introns throughout the respective gene, as it can substantially enhance the gene expression. To facilitate synthetic biology approaches in this microalga, we developed a novel strategy for intron insertion into synthetic DNA fragments. Our method aligns with current MoClo standards, and its feasibility is demonstrated by assembling genes of various lengths and successfully expressing them in C. reinhardtii. Examples include enhanced NanoLuc expression with increased intron numbers, a fungal luciferase enabling bioluminescence in C. reinhardtii,andafungal tryptophandecarboxylase.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Chronology of transcriptome and proteome expression during early Arabidopsis flower development

  • Álvarez-Urdiola, Raquel|||0000-0001-8943-5147
  • Matus, José Tomás|||0000-0002-9196-1813
  • González-Miguel, Víctor M.|||0009-0006-8963-4588
  • Bernardo-Faura, Martí|||0000-0002-8023-3263
  • Riechmann, José Luis|||0000-0003-1108-1945
The complex gene regulatory landscape underlying early flower development in Arabidopsis has been extensively studied through transcriptome profiling, and gene networks controlling floral organ development have been derived from the analyses of genome-wide binding of key transcription factors. In contrast, the dynamic nature of the proteome during the flower development process is much less understood. In this study, we characterized the floral proteome at different stages during early flower development and correlated it with unbiased transcript expression data. Shotgun proteomics and transcript profiling were conducted using an APETALA1 (AP1)-based floral induction system. A specific analysis pipeline to process the time-course proteomics data was developed. In total, 8924 proteins and 23 069 transcripts were identified. Co-expression analysis revealed that RNA-protein pairs clustered in various expression pattern modules. An overall positive correlation between RNA and protein level changes was observed, but subgroups of RNA-protein pairs with anti-correlated gene expression changes were also identified and found to be enriched in hormone-responsive pathways. In addition, the RNA-seq dataset reported here further expanded the identification of genes whose expression changes during early flower development, and its combination with previously published AP1 ChIP-seq datasets allowed the identification of additional direct and high-confidence targets of AP1.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

MoCloro, an extension of the Chlamydomonas reinhardtii modular cloning toolkit for microalgal chloroplast engineering

  • Melero-Cobo, Xavier|||0000-0003-1509-4946
  • Gallemí, Marçal|||0000-0003-4675-6893
  • Carnicer, Marc|||0000-0003-4459-5969
  • Monte, Elena|||0000-0002-7340-9355
  • Planas, Antoni|||0000-0001-7073-3320
  • Leivar, Pablo|||0000-0003-4878-3684
Photosynthetic microalgae are promising green cell factories for the sustainable production of high-value chemicals and biopharmaceuticals. The chloroplast organelle is being developed as a chassis for synthetic biology as it contains its own genome (the plastome) and some interesting advantages, such as high recombinant protein titers and a diverse and dynamic metabolism. However, chloroplast engineering is currently hampered by the lack of standardized cloning tools and Design-Build-Test-Learn workflows to ease genomic and metabolic engineering. The MoClo (Modular Cloning) toolkit based on Golden Gate assembly was recently developed in the model eukaryotic green microalgae Chlamydomonas reinhardtii to facilitate nuclear transformation and engineering. Here, we present MoCloro as an extension of the MoClo that allows chloroplast genome engineering. Briefly, a Golden Gate-compatible chloroplast transformation vector (pWF.K.4) was constructed, which contains homologous arms for integration at the petA site in the plastome. A collection of standardized parts (promoters, terminators, reporter and selection marker genes) was created following the MoClo syntax to enable easy combinatorial assembly of multi-cassettes in the destination pWF.K.4 vector. The functionality of the biobricks was assayed by constructing and assessing the expression of several multigenic constructs. Finally, a generic vector pK4 was constructed for easy Golden Gate cloning of 5' and 3' homologous arms, allowing targeting at alternative plastome integration sites. This work represents a significant advancement in technology aimed at facilitating more efficient and rapid chloroplast transformation and engineering of green microalgae.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A PIF-regulated switch in cell axis growth drives cotyledon expansion through tissue-specific cell expansion and division

  • Veciana Fonts, Nil|||0000-0002-1761-6616
  • Martín, Guiomar|||0000-0001-6642-1666
  • Monte, Elena|||0000-0002-7340-9355
Despite its crucial role during seedling deetiolation, cotyledon expansion has been largely overlooked, with hypocotyl elongation favored as the primary phenotypic readout in light signaling research. Here, we investigate how cotyledon expansion is regulated during seedling establishment and reveal that light-induced cotyledon expansion involves a rapid switch in growth direction - from longitudinal in darkness to transversal upon initial light exposure. Using PIFq- and phyA/phyB-deficient Arabidopsis mutants, we demonstrate that this switch is repressed by PIFs in the dark and promoted by phytochromes under red light. Notably, expansion is antagonistically regulated in the light by GUN1-mediated plastid retrograde signaling. Cotyledon expansion involves rapid epidermis cell expansion, transitioning from rectangular in darkness to characteristic lobed cells in light. Importantly, our findings show that mesophyll extension is driven not only by cell enlargement but also by palisade cell division, consistent with an enrichment of cell cycle-related genes that are antagonistically regulated by the PIF/phy system and retrograde signaling in the cotyledon. Finally, using mutant lines expressing PIF1 and phyB specifically in the epidermis, we establish that epidermal expansion can drive palisade cell growth, while mesophyll cell division is predominantly regulated by light at the tissue-specific level. This study provides a novel framework for investigating cotyledon expansion during seedling deetiolation, incorporating tissue-level regulation. We propose that cotyledons serve as an excellent model for studying morphogenesis and organ geometry, which in plants is governed by directional cell growth.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

The 'non-conventional' peptidome, A new layer in plant regulatory mechanisms

  • Álvarez-Urdiola, Raquel|||0000-0001-8943-5147
  • Riechmann, José Luis|||0000-0003-1108-1945
A substantial but largely unexplored fraction of eukaryotic proteomes is composed of peptides and small proteins (the peptidome). In recent years, short open reading frames (sORFs) capable of encoding functional peptides have been identified within transcripts annotated as non-coding RNAs or in intergenic regions. These sORF-encoded peptides (SEPs) were previously overlooked due to their small size and difficulties in detection, both experimentally and computationally. However, analyses of translating RNAs (ribosome profiling) and proteomics (mass spectrometry) have provided growing evidence for the existence of numerous novel 'non-conventional' peptides in eukaryotic organisms, including plants. In animals, mounting evidence indicates that long non-coding RNAs are an important source of SEPs, and that SEPs participate in crucial cellular and physiological processes and can mediate the evolution of novel characteristics. Similar findings are now emerging in plants. The SEP-coding capacity and the full repertoire of functional SEPs within eukaryotic genomes remain unclear, but systematic, large-scale molecular screenings are beginning to address this gap. Here, we review current progress in understanding the plant non-conventional peptidome, explore parallels between plants and animals, and illustrate how findings in animals can help guide plant research on this topic.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

NGATHA carpel development genes evolved in the common ancestor of seed plants

  • Cota, Ignacio|||0000-0003-3367-7037
  • Moschin, Silvia
  • Offer, Elisabetta
  • Martínez-Fernández, Irene
  • Magnanimi, Francesco
  • Ambrose, Barbara
  • Nigris, Sebastiano
  • Baldan, Barbara
  • Ferrándiz, Cristina
  • Pelaz, Soraya|||0000-0001-7699-9330
The evolution of the carpel, the defining feature of angiosperms, remains a fundamental question in plant biology. Understanding how this organ originated is crucial because it underpins the reproductive success and diversity of flowering plants. Here, we investigated the functional conservation between gymnosperms and angiosperms of key transcription factors involved in carpel development. We found that Ginkgo biloba homologs can functionally substitute for their angiosperm counterparts in stigma development. We discovered that GbRAV5 is related to angiosperm NGA genes, challenging previous notions that these are exclusive to angiosperms, and we found a parallel loss of the AP2 domain in gymnosperms providing a rare snapshot of how protein families evolve. Conserved protein interactions and overlapping expression patterns of GbRAV5 and GbHEC in Ginkgo ovules suggest that the molecular toolkit for carpel development was largely present in the last common ancestor of seed plants, offering new insights into the evolution of reproductive structures.
Repisalud
Publication Artículo científico (JournalArticle)

Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatment.

  • Salvador-Martín, Sara
  • Rubbini, Gianluca
  • Vellosillo, Perceval
  • Zapata-Cobo, Paula
  • Velasco, Marta
  • Palomino, Laura M
  • Clemente, Susana
  • Segarra, Oscar
  • Moreno-Álvarez, Ana
  • Fernández-Lorenzo, Ana
  • Pérez-Moneo, Begoña
  • Montraveta, Montserrat
  • Sánchez, Cesar
  • Tolín, Mar
  • Loverdos, Inés
  • Fobelo, María José
  • Navas-López, Victor Manuel
  • Magallares, Lorena
  • García-Romero, Ruth
  • Torres-Peral, Ricardo
  • Rodríguez, Alejandro
  • Bossacoma, Ferrán
  • Merino-Bohórquez, Vicente
  • Salcedo, Enrique
  • Álvarez, Rebeca
  • Dopazo, Ana
  • Sanjurjo-Sáez, María
  • López-Fernández, Luis A
Changes in gene expression profiles among individuals with inflammatory bowel diseases (IBDs) could potentially influence the responsiveness to anti-TNF treatment. The aim of this study was to identify genes that could serve as predictors of early response to anti-TNF therapies in pediatric IBD patients prior to the initiation of treatment. We conducted a prospective, longitudinal, and multicenter study, enrolling 24 pediatric IBD patients aged less than 18 years who were initiating treatment with either infliximab or adalimumab. RNA-seq from blood samples was analyzed using the DESeq2 library by comparing responders and non-responders to anti-TNF drugs. Bioinformatic analyses unveiled 102 differentially expressed genes, with 99 genes exhibiting higher expression in responders compared to non-responders prior to the initiation of anti-TNF therapy. Functional enrichment analyses highlighted defense response to Gram-negative bacteria (FDR = 2.3 ×10-7) as the most significant biological processes, and hemoglobin binding (FDR = 0.002), as the most significant molecular function. Gene Set Enrichment Analysis (GSEA) revealed notable enrichment in transcriptional misregulation in cancer (FDR = 0.016). Notably, 13 genes (CEACAM8, CEACAM6, CILP2, COL17A1, OLFM4, INHBA, LCN2, LTF, MMP8, DEFA4, PRTN3, AZU1, and ELANE) were selected for validation, and a consistent trend of increased expression in responders prior to drug administration was observed for most of these genes, with findings for 4 of them being statistically significant (CEACAM8, LCN2, LTF2, and PRTN3). We identified 102 differentially expressed genes involved in the response to anti-TNF drugs in children with IBDs and validated CEACAM8, LCN2, LTF2, and PRTN3. Genes participating in defense response to Gram-negative bacterium, serine-type endopeptidase activity, and transcriptional misregulation in cancer are good candidates for anticipating the response to anti-TNF drugs in children with IBDs.
Repisalud
Publication Artículo científico (JournalArticle)

Novel risk loci for COVID-19 hospitalization among admixed American populations

  • Diz-de Almeida, Silvia
  • Cruz, Raquel
  • Luchessi, Andre D
  • Lorenzo-Salazar, José M
  • López de Heredia, Miguel
  • Quintela, Inés
  • González-Montelongo, Rafaela
  • Nogueira Silbiger, Vivian
  • Porras, Marta Sevilla
  • Tenorio Castaño, Jair Antonio
  • Nevado, Julián
  • Aguado, José María
  • Aguilar, Carlos
  • Aguilera-Albesa, Sergio
  • Almadana, Virginia
  • Almoguera, Berta
  • Alvarez, Nuria
  • Andreu-Bernabeu, Álvaro
  • Arana-Arri, Eunate
  • Arango, Celso
  • Arranz, María J
  • Artiga, Maria-Jesus
  • Baptista-Rosas, Raúl C
  • Barreda-Sánchez, María
  • Belhassen-García, Moncef
  • Bezerra, Joao F
  • Bezerra, Marcos A C
  • Boix-Palop, Lucía
  • Brion, María
  • Brugada, Ramón
  • Bustos, Matilde
  • Calderón, Enrique J
  • Carbonell, Cristina
  • Castano, Luis
  • Castelao, Jose E
  • Conde-Vicente, Rosa
  • Cordero-Lorenzana, M Lourdes
  • Cortes-Sanchez, Jose L
  • Corton, Marta
  • Darnaude, M Teresa
  • De Martino-Rodríguez, Alba
  • Del Campo-Pérez, Victor
  • Diaz de Bustamante, Aranzazu
  • Domínguez-Garrido, Elena
  • Eirós, Rocío
  • Fariñas, María Carmen
  • Fernandez-Nestosa, María J
  • Fernández-Robelo, Uxía
  • Fernandez-Rodriguez, Amanda
  • Fernández-Villa, Tania
  • Gago-Dominguez, Manuela
  • Gil-Fournier, Belén
  • Gómez-Arrue, Javier
  • González Álvarez, Beatriz
  • González Bernaldo de Quirós, Fernan
  • González-Neira, Anna
  • González-Peñas, Javier
  • Gutiérrez-Bautista, Juan F
  • Herrero, María José
  • Herrero-Gonzalez, Antonio
  • Jimenez-Sousa, Maria Angeles
  • Lattig, María Claudia
  • Liger Borja, Anabel
  • Lopez-Rodriguez, Rosario
  • Mancebo, Esther
  • Martín-López, Caridad
  • Martín, Vicente
  • Martinez-Nieto, Oscar
  • Martinez-Lopez, Iciar
  • Martinez-Resendez, Michel F
  • Martinez-Perez, Angel
  • Mazzeu, Juliana F
  • Merayo Macías, Eleuterio
  • Minguez, Pablo
  • Moreno Cuerda, Victor
  • Oliveira, Silviene F
  • Ortega-Paino, Eva
  • Pompa-Mera, Ericka N
  • Parellada, Mara
  • Paz-Artal, Estela
  • Santos, Ney PC
  • Pérez-Matute, Patricia
  • Perez, Patricia
  • Pérez-Tomás, M Elena
  • Perucho, Teresa
  • Pinsach-Abuin, Mel·lina
  • Pita, Guillermo
  • Porras-Hurtado, Gloria L
  • Pujol, Aurora
  • Ramiro León, Soraya
  • Resino, Salvador
  • Fernandes, Marianne R
  • Rodríguez-Ruiz, Emilio
  • Rodríguez-Artalejo, Fernando
  • Rodriguez-Garcia, José A
  • Ruiz-Cabello, Francisco
  • Ruiz-Hornillos, Javier
  • Ryan, Pablo
  • Soria, José Manuel
  • Souto, Juan Carlos
  • Tamayo, Eduardo
  • Tamayo-Velasco, Álvaro
  • Taracido-Fernandez, Juan Carlos
  • Teper, Alejandro
  • Torres-Tobar, Lilian
  • Urioste, Miguel
  • Valencia-Ramos, Juan
  • Yáñez, Zuleima
  • Zarate, Ruth
  • de Rojas, Itziar
  • Ruiz, Agustín
  • Sánchez, Pascual
  • Real, Luis Miguel
  • SCOURGE Cohort Group
  • Guillén-Navarro, Encarna
  • Ayuso, Carmen
  • Parra, Esteban
  • Riancho, José A
  • Rojas-Martinez, Augusto
  • Flores, Carlos
The genetic basis of severe COVID-19 has been thoroughly studied, and many genetic risk factors shared between populations have been identified. However, reduced sample sizes from non-European groups have limited the discovery of population-specific common risk loci. In this second study nested in the SCOURGE consortium, we conducted a genome-wide association study (GWAS) for COVID-19 hospitalization in admixed Americans, comprising a total of 4702 hospitalized cases recruited by SCOURGE and seven other participating studies in the COVID-19 Host Genetic Initiative. We identified four genome-wide significant associations, two of which constitute novel loci and were first discovered in Latin American populations ( and ). A trans-ethnic meta-analysis revealed another novel cross-population risk locus in . Finally, we assessed the performance of a cross-ancestry polygenic risk score in the SCOURGE admixed American cohort. This study constitutes the largest GWAS for COVID-19 hospitalization in admixed Latin Americans conducted to date. This allowed to reveal novel risk loci and emphasize the need of considering the diversity of populations in genomic research.
Repisalud
Publication Artículo científico (JournalArticle)

Whole Transcription Profile of Responders to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease

  • Salvador-Martín, Sara
  • Kaczmarczyk, Bartosz
  • Álvarez, Rebeca
  • Navas-López, Víctor Manuel
  • Gallego-Fernández, Carmen
  • Moreno-Álvarez, Ana
  • Solar-Boga, Alfonso
  • Sánchez, Cesar
  • Tolin, Mar
  • Velasco, Marta
  • Muñoz-Codoceo, Rosana
  • Rodriguez-Martinez, Alejandro
  • Vayo, Concepción A.
  • Bossacoma, Ferrán
  • Pujol-Muncunill, Gemma
  • Fobelo, María J.
  • Millán-Jiménez, Antonio
  • Magallares, Lorena
  • Martínez-Ojinaga, Eva
  • Loverdos, Inés
  • Eizaguirre, Francisco J.
  • Blanca-García, José A.
  • Clemente, Susana
  • García-Romero, Ruth
  • Merino-Bohórquez, Vicente
  • González de Caldas, Rafael
  • Vázquez, Enrique
  • Dopazo, Ana
  • Sanjurjo-Sáez, María
  • López-Fernández, Luis A.
Background: Up to 30% of patients with pediatric inflammatory bowel disease (IBD) do not respond to anti-Tumor Necrosis Factor (anti-TNF) therapy. The aim of this study was to identify pharmacogenomic markers that predict early response to anti-TNF drugs in pediatric patients with IBD. Methods: An observational, longitudinal, prospective cohort study was conducted. The study population comprised 38 patients with IBD aged < 18 years who started treatment with infliximab or adalimumab (29 responders and nine non-responders). Whole gene expression profiles from total RNA isolated from whole blood samples of six responders and six non-responders taken before administration of the biologic and after two weeks of therapy were analyzed using next-generation RNA sequencing. The expression of six selected genes was measured for purposes of validation in all of the 38 patients recruited using qPCR. Results: Genes were differentially expressed in non-responders and responders (32 before initiation of treatment and 44 after two weeks, Log2FC (Fold change) >0.6 or <−0.6 and p value < 0.05). After validation, FCGR1A, FCGR1B, and GBP1 were overexpressed in non-responders two weeks after initiation of anti-TNF treatment (Log2FC 1.05, 1.21, and 1.08, respectively, p value < 0.05). Conclusion: Expression of the FCGR1A, FCGR1B, and GBP1 genes is a pharmacogenomic biomarker of early response to anti-TNF agents in pediatric IBD.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

NGATHA carpel development genes evolved in the common ancestor of seed plants

  • Cota, Ignacio
  • Moschin, Silvia
  • Offer, Elisabetta
  • Magnanimi, Francesco
  • Ambrose, Barbara
  • Nigris, Sebastiano
  • Baldan, Barbara
  • Pelaz, Soraya
  • Martinez-Fernandez, Irene|||0000-0002-3386-779X
  • FERRANDIZ MAESTRE, CRISTINA|||0000-0002-2460-1068
[EN] The evolution of the carpel, the defining feature of angiosperms, remains a fundamental question in plant biology. Understanding how this organ originated is crucial because it underpins the reproductive success and diversity of flowering plants. Here, we investigated the functional conservation between gymnosperms and angiosperms of key transcription factors involved in carpel development. We found that Ginkgo biloba homologs can functionally substitute for their angiosperm counterparts in stigma development. We discovered that GbRAV5 is related to angiosperm NGA genes, challenging previous notions that these are exclusive to angiosperms, and we found a parallel loss of the AP2 domain in gymnosperms providing a rare snapshot of how protein families evolve. Conserved protein interactions and overlapping expression patterns of GbRAV5 and GbHEC in Ginkgo ovules suggest that the molecular toolkit for carpel development was largely present in the last common ancestor of seed plants, offering new insights into the evolution of reproductive structures., We thank LarsØstergaard and Charles P. Scutt for providing seed material, Michael Purugganan for critical reading of the manuscript, and Lucía Campos-Dominguez for advice in bioinformatic analysis and support. This project was financially supported by grant PID2021-127095NB-I00 funded by MICIU/AEI/10.13039/ 501100011033 and by ERDF/EU ; grant FJCI-2017-32273 funded by MICIU/AEI/10.13039/501100011033 (to IC); 2021 SGR 00792 from the CERCA Programme/Generalitat de Catalunya; RED2022- 134917-T MICIN/AEI; and the European Union s Horizon 2020 research and innovation program under the Marie SklodowskaCurie grant agreement No 101007738. We acknowledge financial support from the Grant CEX2019-000902-S funded by MICIU/AEI/ 10.13039/501100011033.
DAU Arxiu Digital de la Universitat Ramon Llull
Publication Artículo científico (JournalArticle)

MoCloro: an extension of the Chlamydomonas reinhardtii modular cloning toolkit for microalgal chloroplast engineering

  • Melero-Cobo, Xavier
  • Gallemi, Marcal
  • Carnicer Heras, Marc
  • Monte, Elena
  • Planas, Antoni
  • Leivar, Pablo
Photosynthetic microalgae are promising green cell factories for the sustainable production of high-value chemicals and biopharmaceuticals. The chloroplast organelle is being developed as a chassis for synthetic biology as it contains its own genome (the plastome) and some interesting advantages, such as high recombinant protein titers and a diverse and dynamic metabolism. However, chloroplast engineering is currently hampered by the lack of standardized cloning tools and Design-Build-Test-Learn workflows to ease genomic and metabolic engineering. The MoClo (Modular Cloning) toolkit based on Golden Gate assembly was recently developed in the model eukaryotic green microalgae Chlamydomonas reinhardtii to facilitate nuclear transformation and engineering. Here, we present MoCloro as an extension of the MoClo that allows chloroplast genome engineering. Briefly, a Golden Gate-compatible chloroplast transformation vector (pWF.K.4) was constructed, which contains homologous arms for integration at the petA site in the plastome. A collection of standardized parts (promoters, terminators, reporter and selection marker genes) was created following the MoClo syntax to enable easy combinatorial assembly of multi-cassettes in the destination pWF.K.4 vector. The functionality of the biobricks was assayed by constructing and assessing the expression of several multigenic constructs. Finally, a generic vector pK4 was constructed for easy Golden Gate cloning of 5′ and 3′ homologous arms, allowing targeting at alternative plastome integration sites. This work represents a significant advancement in technology aimed at facilitating more efficient and rapid chloroplast transformation and engineering of green microalgae., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

MoCloro: an extension of the Chlamydomonas reinhardtii modular cloning toolkit for microalgal chloroplast engineering

  • Melero-Cobo, Xavier
  • Gallemi, Marcal
  • Carnicer Heras, Marc
  • Monte, Elena
  • Planas, Antoni
  • Leivar, Pablo
Photosynthetic microalgae are promising green cell factories for the sustainable production of high-value chemicals and biopharmaceuticals. The chloroplast organelle is being developed as a chassis for synthetic biology as it contains its own genome (the plastome) and some interesting advantages, such as high recombinant protein titers and a diverse and dynamic metabolism. However, chloroplast engineering is currently hampered by the lack of standardized cloning tools and Design-Build-Test-Learn workflows to ease genomic and metabolic engineering. The MoClo (Modular Cloning) toolkit based on Golden Gate assembly was recently developed in the model eukaryotic green microalgae Chlamydomonas reinhardtii to facilitate nuclear transformation and engineering. Here, we present MoCloro as an extension of the MoClo that allows chloroplast genome engineering. Briefly, a Golden Gate-compatible chloroplast transformation vector (pWF.K.4) was constructed, which contains homologous arms for integration at the petA site in the plastome. A collection of standardized parts (promoters, terminators, reporter and selection marker genes) was created following the MoClo syntax to enable easy combinatorial assembly of multi-cassettes in the destination pWF.K.4 vector. The functionality of the biobricks was assayed by constructing and assessing the expression of several multigenic constructs. Finally, a generic vector pK4 was constructed for easy Golden Gate cloning of 5′ and 3′ homologous arms, allowing targeting at alternative plastome integration sites. This work represents a significant advancement in technology aimed at facilitating more efficient and rapid chloroplast transformation and engineering of green microalgae., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Whole Transcription Profile of Responders to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease

  • Kaczmarczyk, Bartosz
  • Álvarez, Rebeca
  • Navas-López, Víctor Manuel
  • Gallego-Fernández, Carmen
  • Moreno-Álvarez, Ana
  • Clemente Bautista, Susana
  • Salvador-Martín, Sara
Biomarcador; Expressió gènica; Malaltia inflamatòria intestinal, Biomarcador; Expresión génica; Enfermedad inflamatoria intestinal, Biomarker; Gene expression; Inflammatory bowel disease, Background: Up to 30% of patients with pediatric inflammatory bowel disease (IBD) do not respond to anti-Tumor Necrosis Factor (anti-TNF) therapy. The aim of this study was to identify pharmacogenomic markers that predict early response to anti-TNF drugs in pediatric patients with IBD. Methods: An observational, longitudinal, prospective cohort study was conducted. The study population comprised 38 patients with IBD aged < 18 years who started treatment with infliximab or adalimumab (29 responders and nine non-responders). Whole gene expression profiles from total RNA isolated from whole blood samples of six responders and six non-responders taken before administration of the biologic and after two weeks of therapy were analyzed using next-generation RNA sequencing. The expression of six selected genes was measured for purposes of validation in all of the 38 patients recruited using qPCR. Results: Genes were differentially expressed in non-responders and responders (32 before initiation of treatment and 44 after two weeks, Log2FC (Fold change) >0.6 or <−0.6 and p value < 0.05). After validation, FCGR1A, FCGR1B, and GBP1 were overexpressed in non-responders two weeks after initiation of anti-TNF treatment (Log2FC 1.05, 1.21, and 1.08, respectively, p value < 0.05). Conclusion: Expression of the FCGR1A, FCGR1B, and GBP1 genes is a pharmacogenomic biomarker of early response to anti-TNF agents in pediatric IBD., This research was funded by Instituto de Salud Carlos III (grants numbers PI16/00559 and PI19/00792), Consejería de Educación y Deporte de la Comunidad de Madrid (grant number PEJ16/MED/AI-1260), and by the Gregorio Marañón Health Research Institute (grant number PRE-2018-2). The study was cofunded by European Regional Develompment Funds (FEDER) from the European Commission, “A way of making Europe”.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Co-culture of primary CLL cells with bone marrow mesenchymal cells, CD40 ligand and CpG ODN promotes proliferation of chemoresistant CLL cells phenotypically comparable to those proliferating in vivo

  • Purroy i Zuriguel, Noèlia
  • Abrisqueta, Pau|||0000-0001-9625-7422
  • Carabia, Júlia
  • Carpio Segura, Cecilia del Carmen|||0000-0001-9346-0134
  • Palacio-García, Carles|||0000-0002-9085-3327
  • Bosch Albareda, Francesc|||0000-0001-9241-2886
  • Crespo Maull, Marta|||0000-0002-7732-7808
Chronic lymphocytic leukemia (CLL) cells residing in the bone marrow (BM) and in secondary lymphoid tissues receive survival and proliferative signals from the microenvironment, resulting in persistence of residual disease after treatment. In this study, we characterized primary CLL cells cultured with BM stromal cells, CD40 ligand and CpG ODN to partially mimic the microenvironment in the proliferative centers. This co-culture system induced proliferation and chemoresistance in primary CLL cells. Importantly, co-cultured primary CLL cells shared many phenotypical features with circulating proliferative CLL cells, such as upregulation of ZAP-70 and CD38 and higher CD49d and CD62L expression. This indicates aggressiveness and capability to interact with surrounding cells, respectively. In addition, levels of CXCR4 were decreased due to CXCR4 internalization after CXCL12 stimulation by BM stromal cells. We suggest that this co-culture system can be used to test drugs and their combinations that target the proliferative and drug resistant CLL cells.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Inhibition of BCR signaling using the Syk inhibitor TAK-659 prevents stroma-mediated signaling in chronic lymphocytic leukemia cells

  • Purroy i Zuriguel, Noèlia
  • Carabia, Júlia
  • Abrisqueta, Pau|||0000-0001-9625-7422
  • Egia-Mendikute, Leire|||0000-0002-6435-1219
  • Aguiló, Meritxell|||0000-0001-5367-8737
  • Carpio Segura, Cecilia del Carmen|||0000-0001-9346-0134
  • Palacio-García, Carles|||0000-0002-9085-3327
  • Crespo, Marta|||0000-0002-7732-7808
  • Bosch Albareda, Francesc|||0000-0001-9241-2886
Proliferation and survival of chronic lymphocytic leukemia (CLL) cells depend on microenvironmental signals coming from lymphoid organs. One of the key players involved in the crosstalk between CLL cells and the microenvironment is the B-cell receptor (BCR). Syk protein, a tyrosine kinase essential for BCR signaling, is therefore a rational candidate for targeted therapy in CLL. Against this background, we tested the efficacy of the highly specific Syk inhibitor TAK-659 in suppressing the favorable signaling derived from the microenvironment. To ex vivo mimic the microenvironment found in the proliferation centers, we co-cultured primary CLL cells with BM stromal cells (BMSC), CD40L and CpG ODN along with BCR stimulation. In this setting, TAK-659 inhibited the microenvironment-induced activation of Syk and downstream signaling molecules, without inhibiting the protein homologue ZAP-70 in T cells. Importantly, the pro-survival, proliferative, chemoresistant and activation effects promoted by the microenvironment were abrogated by TAK-659, which furthermore blocked CLL cell migration toward BMSC, CXCL12, and CXCL13. Combination of TAK-659 with other BCR inhibitors showed synergistic effect in inducing apoptosis, and the sequential addition of TAK-659 in ibrutinib-treated CLL cells induced significantly higher cytotoxicity. These findings provide a strong rationale for the clinical development of TAK-659 in CLL.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

ZAP-70 Promotes the Infiltration of Malignant B-Lymphocytes into the Bone Marrow by Enhancing Signaling and Migration after CXCR4 Stimulation

  • Calpe, Eva
  • Purroy i Zuriguel, Noèlia
  • Carpio Segura, Cecilia del Carmen|||0000-0001-9346-0134
  • Abrisqueta, Pau|||0000-0001-9625-7422
  • Carabia, Júlia
  • Palacio-García, Carles|||0000-0002-9085-3327
  • Castellvi, Josep|||0000-0001-5745-9996
  • Crespo, Marta|||0000-0002-7732-7808
  • Bosch Albareda, Francesc|||0000-0001-9241-2886
ZAP-70 in chronic lymphocytic leukemia (CLL) is associated with enhanced response to microenvironmental stimuli. We analyzed the functional consequences of ZAP-70 ectopic expression in malignant B-cells in a xenograft mouse model of disseminated B-cell leukemia. Mice injected with B-cells expressing ZAP-70 showed a prominently higher infiltration of the bone marrow. In vitro analysis of the response of malignant B-cells to CXCL12, the main attracting chemokine regulating trafficking of lymphocytes to the bone marrow, or to bone marrow stromal cells, revealed that ZAP-70 induces an increased response in terms of signaling and migration. These effects are probably mediated by direct participation of ZAP-70 in CXCL12-CXCR4 signaling since CXCR4 stimulation led to activation of ZAP-70 and downstream signaling pathways, such as MAPK and Akt, whereas ZAP-70 did not alter the expression of the CXCR4 receptor. In addition, subclones of primary CLL cells with high expression of ZAP-70 also showed increased migrative capacity toward CXCL12. Neutralization of CXCR4 with a monoclonal antibody resulted in impaired in vitro responses to CXCL12 and bone marrow stromal cells. We conclude that ZAP-70 enhances the migration of malignant B-cells into the supportive microenvironment found in the bone marrow mainly by enhancing signaling and migration after CXCR4 stimulation.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Novel genes and sex differences in COVID-19 severity

  • Cruz, Raquel|||0000-0002-6964-8898
  • Diz-de Almeida, Silvia|||0000-0003-2813-8928
  • López de Heredia, Miguel|||0000-0003-2826-9565
  • Quintela, Inés|||0000-0002-0239-7975
  • Ceballos, Francisco C.
  • Pita, Guillermo|||0000-0003-2393-0510
  • Lorenzo-Salazar, José M.
  • González-Montelongo, Rafaela
  • Gago-Dominguez, Manuela
  • Sevilla Porras, Marta
  • Tenorio Castaño, Jair Antonio|||0000-0002-5308-2316
  • Nevado, Julián|||0000-0001-5611-2659
  • Aguado, José María|||0000-0002-9520-8255
  • Aguilar Franco, Carlos
  • Aguilera-Albesa, Sergio|||0000-0003-3540-1448
  • Almadana, Virginia
  • Almoguera, Berta|||0000-0002-5599-2954
  • Alvarez, Nuria
  • Andreu-Bernabeu, Álvaro
  • Arana-Arri, Eunate|||0000-0001-9759-333X
  • Arango, Celso|||0000-0003-3382-4754
  • Arranz, María Jesús|||0000-0002-6757-9198
  • Artiga, Maria-Jesus
  • Baptista-Rosas, Raúl C.|||0000-0002-0273-4740
  • Barreda Sánchez, María
  • Belhassen-Garcia, Moncef
  • Bezerra, Joao F.
  • Bezerra, Marcos A C.
  • Boix-Palop, Lucía|||0000-0002-4080-0008
  • Brion, María|||0000-0001-7463-2148
  • Brugada, Ramon|||0000-0001-6607-3032
  • Bustos, Matilde
  • Calderón, Enrique J.|||0000-0002-3166-5086
  • Carbonell, Cristina|||0000-0002-6271-5111
  • Castaño, Luis|||0000-0003-0437-9401
  • Castelao, Jose E.
  • Conde-Vicente, Rosa
  • Cordero-Lorenzana, M Lourdes
  • Cortes-Sanchez, Jose L.
  • Corton, Marta|||0000-0003-0087-1626
  • Darnaude, M Teresa
  • De Martino-Rodríguez, Alba|||0000-0002-2436-9852
  • Campo Pérez, Víctor del|||0000-0002-9424-9653
  • Diaz de Bustamante, Aranzazu
  • Domínguez-Garrido, Elena|||0000-0002-2066-0511
  • Luchessi, Andre D.
  • Eiros, Rocío
  • Estigarribia Sanabria, Gladys Mercedes
  • Carmen Fariñas, María
  • Fernández-Robelo, Uxía
  • Fernández-Rodríguez, Amanda|||0000-0002-5110-2213
  • Fernández-Villa, Tania|||0000-0002-9049-3026
  • Gil-Fournier, Belén
  • Gómez-Arrue, Javier
  • González Álvarez, Beatriz
  • Gonzalez Bernaldo de Quirós, Fernan
  • González-Peñas, Javier|||0000-0002-3850-3012
  • Gutiérrez-Bautista, Juan F.|||0000-0003-1374-0756
  • Herrero, María José
  • Herrero-Gonzalez, Antonio
  • Jimenez-Sousa, María A.
  • Lattig, María Claudia|||0000-0003-2113-9266
  • Liger Borja, Anabel
  • Lopez-Rodriguez, Rosario
  • Mancebo, Esther
  • Martín-López, Caridad
  • Martín, Vicente|||0000-0003-0552-2804
  • Martinez-Nieto, Oscar
  • Martinez-Lopez, Iciar
  • Martinez-Resendez, Michel F.
  • Martinez-Perez, Angel|||0000-0002-5934-1454
  • Mazzeu, Juliana F.
  • Merayo Macías, Eleuterio
  • Minguez, Pablo|||0000-0003-4099-9421
  • Moreno Cuerda, Victor
  • Silbiger, Vivian N.
  • Oliveira, Silviene F.|||0000-0002-7741-0257
  • Ortega-Paino, Eva
  • Parellada, Mara|||0000-0001-7977-3601
  • Paz-Artal, Estela|||0000-0002-0646-2375
  • Santos, Ney P C.
  • Pérez-Matute, Patricia
  • Perez, Patricia
  • Pérez-Tomás, M. Elena|||0000-0002-5429-3414
  • Perucho, Teresa
  • Pinsach-Abuin, Mel Lina
  • Pompa-Mera, Ericka N.
  • Porras-Hurtado, Gloria L.
  • Pujol, Aurora|||0000-0002-9606-0600
  • Ramiro-León, Soraya
  • Resino, Salvador|||0000-0001-8783-0450
  • Fernandes, Marianne R.
  • Rodríguez-Ruiz, Emilio
  • Rodriguez-Artalejo, Fernando
  • Rodriguez-Garcia, José A.
  • Ruiz Cabello, Francisco
  • Ruiz-Hornillos, Javier
  • Ryan, Pablo|||0000-0002-4212-7419
  • Soria Fernández, José Manuel|||0000-0002-6226-4293
  • Souto, Juan Carlos|||0000-0003-2092-5142
  • Tamayo, Eduardo
  • Tamayo-Velasco, Alvaro
  • Taracido-Fernandez, Juan Carlos
  • Teper, Alejandro
  • Torres-Tobar, Lilian
  • Urioste, Miguel|||0000-0001-7583-7305
  • Valencia-Ramos, Juan
  • Yáñez, Zuleima
  • Zarate, Ruth N.
  • Nakanishi, Tomoko|||0000-0001-9510-5646
  • Pigazzini, Sara
  • Degenhardt, Frauke|||0000-0001-7516-3179
  • Butler-Laporte, Guillaume|||0000-0001-5388-0396
  • Maya-Miles, Douglas|||0000-0002-0669-6526
  • Bujanda, Luis|||0000-0002-4353-9968
  • Bouysran, Youssef|||0000-0003-1368-6550
  • Palom, Adriana|||0000-0002-0130-1302
  • Ellinghaus, David|||0000-0002-4332-6110
  • Martínez-Bueno, Manuel
  • Rolker, Selina
  • Amitrano, Sara
  • Roade, Luisa|||0000-0002-8160-9613
  • Fava, Francesca
  • Spinner, Christoph D.|||0000-0002-3875-5367
  • Prati, Daniele|||0000-0002-2281-7498
  • Bernardo, D.|||0000-0002-2843-6696
  • Garcia, Federico
  • Darcis, Gilles|||0000-0001-8192-1351
  • Fernández Cadenas, Israel|||0000-0003-4821-2363
  • Holter, Jan Cato
  • Banales, Jesus|||0000-0002-5224-2373
  • Frithiof, Robert
  • Duga, Stefano
  • Asselta, Rosanna
  • Pereira, Alexandre C.
  • Romero-Gómez, Manuel|||0000-0001-8494-8947
  • Nafria-Jimenez, Beatriz|||0000-0002-4698-5680
  • Hov, Johannes R.|||0000-0002-5900-8096
  • Migeotte, Isabelle
  • Renieri, Alessandra|||0000-0002-0846-9220
  • Planas, Anna Maria|||0000-0002-6147-1880
  • Ludwig, Kerstin U.|||0000-0002-8541-2519
  • Buti, Maria|||0000-0002-0732-3078
  • Rahmouni, Souad
  • Alarcón-Riquelme, Marta E.|||0000-0002-7632-4154
  • Schulte, Eva C.|||0000-0003-3105-5672
  • Franke, Andre|||0000-0003-1530-5811
  • Karlsen, Tom H.
  • Valenti, Luca|||0000-0001-8909-0345
  • Zeberg, Hugo
  • Richards, Brent
  • Ganna, Andrea|||0000-0002-8147-240X
  • Boada, Mercè|||0000-0003-2617-3009
  • De Rojas, Itziar|||0000-0002-2148-381X
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
  • Sánchez-Juan, Pascual|||0000-0002-6081-8037
  • Real, Luis M.|||0000-0003-4932-7429
  • Guillén-Navarro, Encarna|||0000-0002-2915-7381
  • Ayuso, Carmen|||0000-0002-9606-6957
  • González-Neira, Anna
  • Riancho, José A.|||0000-0003-0691-8755
  • Rojas-Martinez, Augusto|||0000-0003-3765-6778
  • Flores, Carlos|||0000-0001-5352-069X
  • Lapunzina, Pablo|||0000-0002-6324-4825
  • Carracedo, Ángel|||0000-0003-1085-8986
Here, we describe the results of a genome-wide study conducted in 11 939 coronavirus disease 2019 (COVID-19) positive cases with an extensive clinical information that were recruited from 34 hospitals across Spain (SCOURGE consortium). In sex-disaggregated genome-wide association studies for COVID-19 hospitalization, genome-wide significance (P < 5 × 10 -8) was crossed for variants in 3p21.31 and 21q22.11 loci only among males (P = 1.3 × 10 -22 and P = 8.1 × 10 -12, respectively), and for variants in 9q21.32 near TLE1 only among females (P = 4.4 × 10 -8). In a second phase, results were combined with an independent Spanish cohort (1598 COVID-19 cases and 1068 population controls), revealing in the overall analysis two novel risk loci in 9p13.3 and 19q13.12, with fine-mapping prioritized variants functionally associated with AQP3 (P = 2.7 × 10 -8) and ARHGAP33 (P = 1.3 × 10 -8), respectively. The meta-analysis of both phases with four European studies stratified by sex from the Host Genetics Initiative (HGI) confirmed the association of the 3p21.31 and 21q22.11 loci predominantly in males and replicated a recently reported variant in 11p13 (ELF5, P = 4.1 × 10 -8). Six of the COVID-19 HGI discovered loci were replicated and an HGI-based genetic risk score predicted the severity strata in SCOURGE. We also found more SNP-heritability and larger heritability differences by age (<60 or ≥60 years) among males than among females. Parallel genome-wide screening of inbreeding depression in SCOURGE also showed an effect of homozygosity in COVID-19 hospitalization and severity and this effect was stronger among older males. In summary, new candidate genes for COVID-19 severity and evidence supporting genetic disparities among sexes are provided.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Il-15 enhances the persistence and function of bcma-targeting car-t cells compared to il-2 or il-15/il-7 by limiting car-t cell dysfunction and differentiation

  • Battram, Anthony M.|||0000-0002-9179-0639
  • Bachiller, Mireia|||0000-0002-6153-4722
  • Lopez, Victor
  • Fernandez de Larrea Rodriguez, Carlos
  • Urbano Ispizua, Álvaro|||0000-0002-7529-9399
  • Martín-Antonio, B.|||0000-0003-0612-2693
Chimeric antigen receptor (CAR)-T cell immunotherapy has revolutionized the treatment of B-lymphoid malignancies. For multiple myeloma (MM), B-cell maturation antigen (BCMA)-targeted CAR-T cells have achieved outstanding complete response rates, but unfortunately, patients often relapse within a year of receiving the therapy. Increased persistence and reduced dysfunction are crucial features that enhance the durability of CAR-T cell responses. One of the factors that influence CAR-T cell in vivo longevity and loss of function, but which has not yet been extensively studied for BCMA-directed CAR-T cells, are the cytokines used during their production. We here compared the impact of IL-2, IL-15 and a combination of IL-15/IL-7 on the phenotype and function of ARI2h, an academic BCMA-directed CAR-T cell that is currently being administered to MM patients. For this study, flow cytometry, in vitro cytotoxicity assays and analysis of cytokine release were performed. In addition, ARI2h cells expanded with IL-2, IL-15, or IL-15/IL-7 were injected into MM tumor-bearing mice to assess their in vivo efficacy. We demonstrated that each of the cytokine conditions was suitable for the expansion of ARI2h cells, with clear in vitro activity. Strikingly, however, IL-15-produced ARI2h cells had improved in vivo efficacy and persistence. When explored further, it was found that IL-15 drove a less-differentiated ARI2h phenotype, ameliorated parameters related to CAR-T cell dysfunction, and lowered the release of cytokines potentially involved in cytokine release syndrome and MM progression. Moreover, we observed that IL-15 was less potent in inducing T cell senescence and DNA damage accumulation, both of which may contribute to an unfavorable CAR-T cell phenotype. These findings show the superiority of IL-15 to IL-2 and IL-15/IL-7 in the quality of anti-BCMA CAR-T cells, particularly their efficacy and persistence, and as such, could improve the duration of responses if applied to the clinical production of CAR-T cells for patients.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatment

  • Salvador-Martín, Sara
  • Rubbini, Gianluca
  • Vellosillo, Perceval
  • Zapata-Cobo, Paula|||0000-0003-1907-1709
  • Velasco, Marta
  • Palomino, Laura M.
  • Clemente, Susana|||0000-0001-6272-6438
  • Segarra Canton, Oscar|||0000-0003-2162-1474
  • Moreno-Álvarez, Ana
  • Fernández-Lorenzo, Ana|||0000-0002-8611-5735
  • Pérez-Moneo, Begoña|||0000-0002-7335-848X
  • Montraveta Querol, Maria Montserrat|||0000-0003-3983-5374
  • Sánchez, Cesar
  • Tolín, Mar
  • Loverdos, Inés|||0000-0002-5496-8717
  • Fobelo, María José
  • Navas-López, Víctor Manuel
  • Magallares, Lorena
  • García-Romero, Ruth
  • Torres-Peral, Ricardo
  • Rodríguez, Alejandro
  • Bossacoma, Ferrán
  • Merino-Bohórquez, V.
  • Salcedo, Enrique
  • Álvarez, Rebeca
  • Dopazo, Ana
  • Sanjurjo Sáez, María|||0000-0002-8523-3721
  • Lopez-Fernandez, Luis A.|||0000-0003-3964-5837
Background/aims: Changes in gene expression profiles among individuals with inflammatory bowel diseases (IBDs) could potentially influence the responsiveness to anti-TNF treatment. The aim of this study was to identify genes that could serve as predictors of early response to anti-TNF therapies in pediatric IBD patients prior to the initiation of treatment. Methods: We conducted a prospective, longitudinal, and multicenter study, enrolling 24 pediatric IBD patients aged less than 18 years who were initiating treatment with either infliximab or adalimumab. RNA-seq from blood samples was analyzed using the DESeq2 library by comparing responders and non-responders to anti-TNF drugs. Results: Bioinformatic analyses unveiled 102 differentially expressed genes, with 99 genes exhibiting higher expression in responders compared to non-responders prior to the initiation of anti-TNF therapy. Functional enrichment analyses highlighted defense response to Gram-negative bacteria (FDR = 2.3 ×10-7) as the most significant biological processes, and hemoglobin binding (FDR = 0.002), as the most significant molecular function. Gene Set Enrichment Analysis (GSEA) revealed notable enrichment in transcriptional misregulation in cancer (FDR = 0.016). Notably, 13 genes (CEACAM8, CEACAM6, CILP2, COL17A1, OLFM4, INHBA, LCN2, LTF, MMP8, DEFA4, PRTN3, AZU1, and ELANE) were selected for validation, and a consistent trend of increased expression in responders prior to drug administration was observed for most of these genes, with findings for 4 of them being statistically significant (CEACAM8, LCN2, LTF2, and PRTN3). Conclusions: We identified 102 differentially expressed genes involved in the response to anti-TNF drugs in children with IBDs and validated CEACAM8, LCN2, LTF2, and PRTN3. Genes participating in defense response to Gram-negative bacterium, serine-type endopeptidase activity, and transcriptional misregulation in cancer are good candidates for anticipating the response to anti-TNF drugs in children with IBDs.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Whole Transcription Profile of Responders to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease

  • Kaczmarczyk, Bartosz
  • Álvarez, Rebeca
  • Navas-López, Víctor Manuel
  • Gallego-Fernández, Carmen
  • Moreno-Álvarez, Ana
  • Clemente Bautista, Susana
  • Salvador-Martín, Sara
Biomarcador; Expressió gènica; Malaltia inflamatòria intestinal, Biomarcador; Expresión génica; Enfermedad inflamatoria intestinal, Biomarker; Gene expression; Inflammatory bowel disease, Background: Up to 30% of patients with pediatric inflammatory bowel disease (IBD) do not respond to anti-Tumor Necrosis Factor (anti-TNF) therapy. The aim of this study was to identify pharmacogenomic markers that predict early response to anti-TNF drugs in pediatric patients with IBD. Methods: An observational, longitudinal, prospective cohort study was conducted. The study population comprised 38 patients with IBD aged < 18 years who started treatment with infliximab or adalimumab (29 responders and nine non-responders). Whole gene expression profiles from total RNA isolated from whole blood samples of six responders and six non-responders taken before administration of the biologic and after two weeks of therapy were analyzed using next-generation RNA sequencing. The expression of six selected genes was measured for purposes of validation in all of the 38 patients recruited using qPCR. Results: Genes were differentially expressed in non-responders and responders (32 before initiation of treatment and 44 after two weeks, Log2FC (Fold change) >0.6 or <−0.6 and p value < 0.05). After validation, FCGR1A, FCGR1B, and GBP1 were overexpressed in non-responders two weeks after initiation of anti-TNF treatment (Log2FC 1.05, 1.21, and 1.08, respectively, p value < 0.05). Conclusion: Expression of the FCGR1A, FCGR1B, and GBP1 genes is a pharmacogenomic biomarker of early response to anti-TNF agents in pediatric IBD., This research was funded by Instituto de Salud Carlos III (grants numbers PI16/00559 and PI19/00792), Consejería de Educación y Deporte de la Comunidad de Madrid (grant number PEJ16/MED/AI-1260), and by the Gregorio Marañón Health Research Institute (grant number PRE-2018-2). The study was cofunded by European Regional Develompment Funds (FEDER) from the European Commission, “A way of making Europe”.